Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-02

FDA Approved: METHADOSE — Supplemental Application (SpecGx LLC)

View source ↗

Summary

The FDA approved a supplemental application for METHADOSE (methadone hydrochloride) submitted by SpecGx LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHADOSE (Methadone hydrochloride)

Snippet

SUPPL AP for METHADOSE (METHADONE HYDROCHLORIDE)